We are seeking

three experienced and ambitious vaccine immunologists to play leading roles in the development and clinical evaluation of next-generation vaccines for emerging and outbreak-prone infections. These posts will sit at the interface of pre-clinical development and phase I trials, with direct impact on first-in-human studies and outbreak-responsive programmes. You will have a strong background in vaccinology or immunology, with expertise in vaccine development and/or immunological assay development, preferably across viral‑vector and/or mRNA–LNP platforms. The role spans both pre‑clinical development and phase I clinical trials. You will lead the design, optimisation, validation and troubleshooting of immunological and vaccine‑characterisation assays, supporting ongoing and upcoming pre‑clinical and first‑in‑human studies. The successful candidate will be confident using a broad range of techniques to characterise vaccine constructs and the immune respons...